GMRS

GMR Solutions Inc. Stock Price

NYSE:GMRS Community·US$3.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

GMRS Share Price Performance

US$13.37
-0.61 (-4.36%)
US$13.37
-0.61 (-4.36%)
Price US$13.37

GMRS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Low risk and slightly overvalued.

3 Risks
2 Rewards

GMR Solutions Inc. Key Details

US$5.7b

Revenue

US$3.5b

Cost of Revenue

US$2.2b

Gross Profit

US$2.2b

Other Expenses

US$35.8m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
0.16
38.90%
0.62%
777.1%
View Full Analysis

About GMRS

Founded
2015
Employees
33858
CEO
Nicola Loporcaro
WebsiteView website
globalmedicalresponse.com

GMR Solutions Inc. operates as a provider of emergency medical services (EMS), essential alternate-site, out-of-hospital care, and mobile clinical practice groups in United States. It offers emergent medical services; non-emergent services; and other solutions, such as membership programs, standby and special events, national ambulance contract with the federal emergency management agency, and other state agency and health system contracts to coordinate EMS responses. It serves health systems, large regional systems, and smaller independent hospitals, local communities, health systems, payors, public health and local, state, and federal agencies. The company was incorporated in 2015 and is headquartered in Lewisville, Texas.

Recent GMRS News & Updates

Seeking Alpha May 14

GMR Solutions: An Emergency Responder In Need Of Help

Summary Global Medical Response Solutions' IPO debuted 40% below its initial range, reflecting investor caution amid high leverage and sector challenges. Global Medical trades at a $7.1 billion enterprise value, with adjusted EBITDA multiples near 6x and high single-digit pro forma earnings, following a $1 drop post-IPO. Despite declining patient encounters, Global Medical has improved margins and transportation revenue per patient, showing operational momentum. Significant risks remain: $4.0 billion net debt, KKR control, reimbursement uncertainty, and sector headwinds; I await further deleveraging evidence before considering a position. Read the full article on Seeking Alpha

Recent updates

No updates